Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Indenbaum

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Viruses|June 24, 2022
National Scale Real-Time Surveillance of SARS-CoV-2 Variants Dynamics by Wastewater Monitoring in IsraelItay Bar-Or, Victoria Indenbaum, Merav Weil, et al.
Viruses|December 23, 2022
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Nofar Atari, et al.
Plos One|November 23, 2020
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosisVictoria Indenbaum, Ravit Koren, Shiri Katz-Likvornik, et al.
Vaccines|July 2, 2021
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in IsraelNeta S Zuckerman, Shay Fleishon, Efrat Bucris, et al.
JAMA Network Open|May 23, 2023
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in IsraelMayan Gilboa, Tal Gonen, Noam Barda, et al.
Eclinicalmedicine|October 25, 2021
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort studyGalia Rahav, Yaniv Lustig, Jacob Lavee, et al.
Talanta|March 15, 2026
Chopped optical biosensing enables temporal background subtraction for high-sensitivity fluorescence immunoassaysShmuel Burg, Yossi Yossef Teboul, Meir Cohen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2023
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-upNoam Barda, Yaniv Lustig, Victoria Indenbaum, et al.
Frontiers in Public Health|January 20, 2022
Regressing SARS-CoV-2 Sewage Measurements Onto COVID-19 Burden in the Population: A Proof-of-Concept for Quantitative Environmental SurveillanceItay Bar-Or, Karin Yaniv, Marilou Shagan, et al.
The Lancet. Microbe|March 24, 2023
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort studyGili Regev-Yochay, Yaniv Lustig, Gili Joseph, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Viruses|June 24, 2022
National Scale Real-Time Surveillance of SARS-CoV-2 Variants Dynamics by Wastewater Monitoring in IsraelItay Bar-Or, Victoria Indenbaum, Merav Weil, et al.
Viruses|December 23, 2022
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant RecipientsYana Davidov, Victoria Indenbaum, Nofar Atari, et al.
Plos One|November 23, 2020
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosisVictoria Indenbaum, Ravit Koren, Shiri Katz-Likvornik, et al.
Vaccines|July 2, 2021
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in IsraelNeta S Zuckerman, Shay Fleishon, Efrat Bucris, et al.
JAMA Network Open|May 23, 2023
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in IsraelMayan Gilboa, Tal Gonen, Noam Barda, et al.
Eclinicalmedicine|October 25, 2021
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort studyGalia Rahav, Yaniv Lustig, Jacob Lavee, et al.
Talanta|March 15, 2026
Chopped optical biosensing enables temporal background subtraction for high-sensitivity fluorescence immunoassaysShmuel Burg, Yossi Yossef Teboul, Meir Cohen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2023
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-upNoam Barda, Yaniv Lustig, Victoria Indenbaum, et al.
Frontiers in Public Health|January 20, 2022
Regressing SARS-CoV-2 Sewage Measurements Onto COVID-19 Burden in the Population: A Proof-of-Concept for Quantitative Environmental SurveillanceItay Bar-Or, Karin Yaniv, Marilou Shagan, et al.
The Lancet. Microbe|March 24, 2023
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort studyGili Regev-Yochay, Yaniv Lustig, Gili Joseph, et al.
Pageof 7